Emerging Companies in the Vietnam Risperidone Market | Insights & Key Players 2026

Emerging Companies in the Vietnam Risperidone Market

The Vietnam Risperidone Market is driven by leading pharmaceutical giants, each having a vast market share through their advanced neuroleptic medications and generic formulations for psychiatric management. Key players in the market include Janssen (Johnson & Johnson) Vietnam, Savipharm, and Davipharm.

Vietnam Risperidone Market Overview

According to 6Wresearch, the Vietnam risperidone market is growing rapidly owing to the rising prevalence of mental health disorders, specifically schizophrenia and bipolar disorder, and the increasing social awareness of psychiatric treatments. Risperidone is recognized as a second-generation atypical neuroleptic that balances dopamine and serotonin levels in the brain.

The growth of the market is being contributed from the increased use of generic alternatives and hospital-based psychiatric care. The healthcare infrastructure is becoming more specialized in Vietnam, with an increasing number of mental health facilities and private clinics contributing to the expansion of the pharmaceutical supply chain for antipsychotic drugs.

Competitive Landscape

The competitive landscape of the Vietnam Risperidone Industry includes local manufacturers and international pharmaceutical giants offering a variety of dosage forms, including tablets, orally disintegrating tablets, and extended-release injections. The industry leaders are actively engaged in ensuring the availability of cost-effective generics and innovative delivery systems to develop patient adherence. These companies are focused on expanding their neuropsychiatry portfolios as the clinical demand for mental health solutions increases.

Below is a list of leading players operating in the Vietnam Risperidone Market:

1. Janssen (Johnson & Johnson) Vietnam

Janssen remains a dominant leader, particularly in the premium segment with its long-acting injectable formulations used in major psychiatric hospitals.

2. Savi Pharmaceutical Joint Stock Company

Savipharm is a leading domestic manufacturer known for its high-quality generic Risperidone, produced in modern facilities meeting PIC/S-GMP standards.

3. Dat Vi Phu Pharmaceutical Co., Ltd

Davipharm is a major player providing affordable antipsychotic medications and holds a significant share in the retail pharmacy sector.

4. DHG Pharmaceutical Joint Stock Company

DHG Pharma utilizes its vast distribution network to supply various CNS drugs, including generic risperidone, to rural and urban health centres.

5. Stellapharm J.V. Co., Ltd.

Stellapharm is a key exporter and local supplier of EU-GMP certified generic risperidone, focusing on bioequivalence and international quality standards.

6. Abbott Vietnam

Abbott maintains a strong presence through its acquisition of local manufacturing capabilities, providing trusted branded generics for chronic mental health management.

7. Sandoz Vietnam

Sandoz is a global leader in generic pharmaceuticals that provides high-quality risperidone tablets, often preferred for hospital tenders.

8. Domesco Medical Import-Export Joint Stock Company

Domesco is a prominent local manufacturer that produces a wide range of nervous system medications for the national healthcare system.

9. Pymepharco Joint Stock Company

Pymepharco is a major domestic player focused on high-tech medicinal products, including neuroleptics for hospital-based treatment.

Emerging Companies in the Vietnam Risperidone Market: FAQs